These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 18323593)
21. Autologous serum eye drops for the treatment of dry eye diseases. Kojima T; Higuchi A; Goto E; Matsumoto Y; Dogru M; Tsubota K Cornea; 2008 Sep; 27 Suppl 1():S25-30. PubMed ID: 18813071 [TBL] [Abstract][Full Text] [Related]
22. Autologous serum for ocular surface diseases. Quinto GG; Campos M; Behrens A Arq Bras Oftalmol; 2008; 71(6 Suppl):47-54. PubMed ID: 19274411 [TBL] [Abstract][Full Text] [Related]
23. Dry coating, a novel coating technology for solid pharmaceutical dosage forms. Luo Y; Zhu J; Ma Y; Zhang H Int J Pharm; 2008 Jun; 358(1-2):16-22. PubMed ID: 18467045 [TBL] [Abstract][Full Text] [Related]
24. Presence of free radicals in commonly used ophthalmic preparations. Lockington D; Macdonald E; Gregory M; Stewart P; Caslake M; Ramaesh K Br J Ophthalmol; 2010 Apr; 94(4):525-6. PubMed ID: 20424216 [No Abstract] [Full Text] [Related]
25. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. Borazan M; Karalezli A; Akova YA; Akman A; Kiyici H; Erbek SS Acta Ophthalmol; 2009 Aug; 87(5):549-54. PubMed ID: 18631332 [TBL] [Abstract][Full Text] [Related]
26. [Medicines used for and with children. No, I don't need my drops!]]. Schäfer C Pharm Unserer Zeit; 2009; 38(1):74-82. PubMed ID: 19132652 [No Abstract] [Full Text] [Related]
28. Status of novel drug delivery technology for phytotherapeutics. Musthaba SM; Baboota S; Ahmed S; Ahuja A; Ali J Expert Opin Drug Deliv; 2009 Jun; 6(6):625-37. PubMed ID: 19505192 [TBL] [Abstract][Full Text] [Related]
29. Ophthalmic agents: ointments or drops? Campbell CB Vet Med Small Anim Clin; 1979 Jul; 74(7):971-4. PubMed ID: 257988 [No Abstract] [Full Text] [Related]
31. Epinastine 0.05% ophthalmic solution in contact lens-wearing subjects with a history of allergic conjunctivitis. Nichols KK; Morris S; Gaddie IB; Evans D Eye Contact Lens; 2009 Jan; 35(1):26-31. PubMed ID: 19125045 [TBL] [Abstract][Full Text] [Related]
32. United States cost-effectiveness study of two dry eye ophthalmic lubricants. Wlodarczyk J; Fairchild C Ophthalmic Epidemiol; 2009; 16(1):22-30. PubMed ID: 19191178 [TBL] [Abstract][Full Text] [Related]
33. Allergic hypersensitivity to topical and systemic corticosteroids: a review. Baeck M; Marot L; Nicolas JF; Pilette C; Tennstedt D; Goossens A Allergy; 2009 Jul; 64(7):978-94. PubMed ID: 19416135 [TBL] [Abstract][Full Text] [Related]
34. [Eye and nose drops in premixed form]. Palin AI; Veĭsh MA Aptechn Delo; 1966; 15(4):64-70. PubMed ID: 5990585 [No Abstract] [Full Text] [Related]
35. A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome. Kim EC; Choi JS; Joo CK Am J Ophthalmol; 2009 Feb; 147(2):206-213.e3. PubMed ID: 18848318 [TBL] [Abstract][Full Text] [Related]
36. Antibacterial activity of preservative-free topical anesthetic drops in current use in ophthalmology departments. Pelosini L; Treffene S; Hollick EJ Cornea; 2009 Jan; 28(1):58-61. PubMed ID: 19092407 [TBL] [Abstract][Full Text] [Related]
39. Development and validation of an anion-exchange LC-UV method for the quantification and purity determination of the DNA plasmid pDERMATT. Quaak SG; Nuijen B; Haanen JB; Beijnen JH J Pharm Biomed Anal; 2009 Feb; 49(2):282-8. PubMed ID: 19111423 [TBL] [Abstract][Full Text] [Related]